Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Yahoo Finance · 4 hours ago
Open | 130.17 |
High | 131.20 |
Low | 129.11 |
Mkt Cap | 328.25B |
P/E (TTM) | 145.62 |
Div & Yield | 3.08 & 2.38% |
Prev. Close | 129.67 |
52 Wk. Low | 99.14 |
52 Wk. High | 133.10 |
Related stocks
American multinational pharmaceutical company
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 15.78B | 8.90% ▲ |
Net Income | 4.76B | 68.80% ▲ |
Diluted EPS | 2.07 | 68.50% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.14 | - |
Q1 2024 | $1.87 | $2.07 |
Q4 2023 | -$0.11 | $0.03 |
S&P 500^GSPC | 5,462.55-10.62 (-0.19%) |
Dow 30^DJI | 39,130.54-4.22 (-0.01%) |
Nasdaq^IXIC | 17,686.59-35.00 (-0.20%) |
164.07+32.85% | |
1.2800+24.27% | |
Alphabet Inc.GOOG | 181.32+2.03% |